{"id":"https://openalex.org/W4387572934","doi":"https://doi.org/10.1177/24741264231201778","title":"Use of Adjunctive Corticosteroid With Antivascular Endothelial Growth Factor Agents in the Treatment of Choroidal Neovascular Membrane Associated With Presumed Ocular Histoplasmosis","display_name":"Use of Adjunctive Corticosteroid With Antivascular Endothelial Growth Factor Agents in the Treatment of Choroidal Neovascular Membrane Associated With Presumed Ocular Histoplasmosis","publication_year":2023,"publication_date":"2023-10-12","ids":{"openalex":"https://openalex.org/W4387572934","doi":"https://doi.org/10.1177/24741264231201778","pmid":"https://pubmed.ncbi.nlm.nih.gov/37974925","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10649456"},"language":"en","primary_location":{"id":"doi:10.1177/24741264231201778","doi":"https://doi.org/10.1177/24741264231201778","is_oa":true,"landing_page_url":"https://doi.org/10.1177/24741264231201778","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/24741264231201778?download=true","source":{"id":"https://openalex.org/S4210215442","display_name":"Journal of VitreoRetinal Diseases","issn_l":"2474-1264","issn":["2474-1264","2474-1272"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of VitreoRetinal Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/24741264231201778?download=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017839453","display_name":"Leanne T. Labriola","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Leanne T. Labriola","raw_affiliation_strings":["Sewickley Eye Group, Sewickley, PA, USA","Southwest Pennsylvania Eye Center Washington, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sewickley Eye Group, Sewickley, PA, USA","institution_ids":[]},{"raw_affiliation_string":"Southwest Pennsylvania Eye Center Washington, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044672309","display_name":"Gautam Vangipuram","orcid":"https://orcid.org/0000-0002-5346-9983","observed_orcids":["https://orcid.org/0000-0002-5346-9983"]},"institutions":[{"id":"https://openalex.org/I4210153219","display_name":"Retina Institute","ror":"https://ror.org/05x6pvv95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210153219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gautam Vangipuram","raw_affiliation_strings":["The Retina Institute, Saint Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Retina Institute, Saint Louis, MO, USA","institution_ids":["https://openalex.org/I4210153219"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008934886","display_name":"Arman Zarnegar","orcid":"https://orcid.org/0009-0007-6890-6633","observed_orcids":["https://orcid.org/0009-0007-6890-6633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arman Zarnegar","raw_affiliation_strings":["Sewickley Eye Group, Sewickley, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sewickley Eye Group, Sewickley, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007393442","display_name":"Michael S. Tsipursky","orcid":"https://orcid.org/0000-0002-7693-4294","observed_orcids":["https://orcid.org/0000-0002-7693-4294"]},"institutions":[{"id":"https://openalex.org/I1308343090","display_name":"Carle Foundation Hospital","ror":"https://ror.org/02nfcgd30","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1308343090"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Tsipursky","raw_affiliation_strings":["Retina, Carle Foundation Hospital, Champaign, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina, Carle Foundation Hospital, Champaign, IL, USA","institution_ids":["https://openalex.org/I1308343090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064467064","display_name":"Joseph A. Besecker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51077184","display_name":"Saint Joseph's University","ror":"https://ror.org/05q87sg56","country_code":"US","type":"education","lineage":["https://openalex.org/I51077184"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Besecker","raw_affiliation_strings":["Saint Joseph\u2019s University, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Saint Joseph\u2019s University, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I51077184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049712519","display_name":"Alexandra Almasov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091351","display_name":"Prairie Education and Research Cooperative","ror":"https://ror.org/00d3w5v70","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210091351"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra Almasov","raw_affiliation_strings":["Prairie Education and Research Cooperative, Springfield, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prairie Education and Research Cooperative, Springfield, IL, USA","institution_ids":["https://openalex.org/I4210091351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001367539","display_name":"Kathleen Campbell Garwood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51077184","display_name":"Saint Joseph's University","ror":"https://ror.org/05q87sg56","country_code":"US","type":"education","lineage":["https://openalex.org/I51077184"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Campbell Garwood","raw_affiliation_strings":["Saint Joseph\u2019s University, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Saint Joseph\u2019s University, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I51077184"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010511809","display_name":"Kevin J. Blinder","orcid":"https://orcid.org/0000-0003-3648-3772","observed_orcids":["https://orcid.org/0000-0003-3648-3772"]},"institutions":[{"id":"https://openalex.org/I4210153219","display_name":"Retina Institute","ror":"https://ror.org/05x6pvv95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210153219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin J. Blinder","raw_affiliation_strings":["The Retina Institute, Saint Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Retina Institute, Saint Louis, MO, USA","institution_ids":["https://openalex.org/I4210153219"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5017839453"],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":0.4814,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.60954359,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"7","issue":"6","first_page":"510","last_page":"520"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/choroidal-neovascularization","display_name":"choroidal neovascularization","score":0.9760000109672546},{"id":"https://openalex.org/keywords/presumed-ocular-histoplasmosis-syndrome","display_name":"presumed ocular histoplasmosis syndrome","score":0.9779999852180481},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/intravitreal-corticosteroids","display_name":"intravitreal corticosteroids","score":0.8840000033378601},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7850000262260437},{"id":"https://openalex.org/keywords/visual-acuity-outcomes","display_name":"visual acuity outcomes","score":0.8240000009536743},{"id":"https://openalex.org/keywords/central-subfield-thickness","display_name":"central subfield thickness","score":0.7770000100135803},{"id":"https://openalex.org/keywords/choroidal-neovascular-membrane","display_name":"choroidal neovascular membrane","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9069305658340454},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6925244331359863},{"id":"https://openalex.org/C2781359195","wikidata":"https://www.wikidata.org/wiki/Q5105209","display_name":"Choroidal neovascularization","level":3,"score":0.6647454500198364},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.6186656951904297},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6116114854812622},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.5572258234024048},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.5552453994750977},{"id":"https://openalex.org/C2778903070","wikidata":"https://www.wikidata.org/wiki/Q2211240","display_name":"Triamcinolone acetonide","level":2,"score":0.4974375069141388},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4789567291736603},{"id":"https://openalex.org/C2780318139","wikidata":"https://www.wikidata.org/wiki/Q627625","display_name":"Histoplasmosis","level":2,"score":0.45840388536453247},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.4350619614124298},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40318289399147034},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.21793285012245178},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.1604653000831604},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1252337098121643},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1177/24741264231201778","doi":"https://doi.org/10.1177/24741264231201778","is_oa":true,"landing_page_url":"https://doi.org/10.1177/24741264231201778","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/24741264231201778?download=true","source":{"id":"https://openalex.org/S4210215442","display_name":"Journal of VitreoRetinal Diseases","issn_l":"2474-1264","issn":["2474-1264","2474-1272"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of VitreoRetinal Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10649456","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10649456","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10649456/pdf/10.1177_24741264231201778.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Vitreoretin Dis","raw_type":"Text"},{"id":"pmid:37974925","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37974925","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of vitreoretinal diseases","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/24741264231201778","doi":"https://doi.org/10.1177/24741264231201778","is_oa":true,"landing_page_url":"https://doi.org/10.1177/24741264231201778","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/24741264231201778?download=true","source":{"id":"https://openalex.org/S4210215442","display_name":"Journal of VitreoRetinal Diseases","issn_l":"2474-1264","issn":["2474-1264","2474-1272"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of VitreoRetinal Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320313378","display_name":"Carle Foundation Hospital","ror":"https://ror.org/02nfcgd30"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387572934.pdf","grobid_xml":"https://content.openalex.org/works/W4387572934.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1725048467","https://openalex.org/W1963708464","https://openalex.org/W1972343425","https://openalex.org/W1976030955","https://openalex.org/W1984982511","https://openalex.org/W2008072120","https://openalex.org/W2008576330","https://openalex.org/W2011678962","https://openalex.org/W2044475540","https://openalex.org/W2052006575","https://openalex.org/W2055795196","https://openalex.org/W2058365751","https://openalex.org/W2059256931","https://openalex.org/W2074609211","https://openalex.org/W2083043469","https://openalex.org/W2132123431","https://openalex.org/W2790490979","https://openalex.org/W2887652118","https://openalex.org/W2894938254","https://openalex.org/W2899462088","https://openalex.org/W3160189288"],"related_works":["https://openalex.org/W2074609211","https://openalex.org/W4287576689","https://openalex.org/W1983964315","https://openalex.org/W2322176912","https://openalex.org/W2059256931","https://openalex.org/W2051946810","https://openalex.org/W2601899573","https://openalex.org/W2019156888","https://openalex.org/W2062305620","https://openalex.org/W2017593303"],"abstract_inverted_index":{"Purpose:":[0],"To":[1],"evaluate":[2],"the":[3,112,119,132,138,158,192],"impact":[4],"of":[5,8,73,84,114,151,165,203],"combination":[6],"treatment":[7,63,202,212],"antivascular":[9],"endothelial":[10],"growth":[11],"factor":[12],"(anti-VEGF)":[13],"intravitreal":[14,71,82],"injections":[15,72,83],"and":[16,43,52,75,86,94,225,231],"corticosteroids":[17],"in":[18,38,96,123,134,142,167,177,213],"patients":[19,68,214],"with":[20,62,70,173,215],"choroidal":[21],"neovascularization":[22],"(CNV)":[23],"secondary":[24,205,217],"to":[25,206,218],"presumed":[26],"ocular":[27],"histoplasmosis":[28],"syndrome":[29],"(POHS).":[30],"Methods:":[31],"A":[32],"retrospective":[33],"multicenter":[34],"study":[35,59],"was":[36,126,175],"conducted":[37],"a":[39,57,146],"cohort":[40],"from":[41,157],"Illinois":[42],"Missouri.":[44],"Patients":[45,141],"were":[46,54,105],"identified":[47],"over":[48,56],"an":[49,234],"8-year":[50],"period,":[51],"data":[53],"evaluated":[55],"1-year":[58,193],"window":[60],"commencing":[61],"initiation.":[64],"Group":[65],"1":[66,136,179],"included":[67,78],"treated":[69],"anti-VEGF,":[74],"group":[76,124,135,143,178,185],"2":[77,125,144,186],"those":[79],"who":[80],"received":[81],"anti-VEGF":[85,229],"adjuvant":[87],"corticosteroids.":[88],"Optical":[89],"coherence":[90],"tomography":[91],"(OCT)":[92],"measurements":[93],"increases":[95],"Early":[97],"Treatment":[98],"Diabetic":[99],"Retinopathy":[100],"Study":[101],"(ETDRS)":[102],"letter":[103,149],"score":[104],"compared":[106,172],"between":[107],"each":[108],"group.":[109],"Results:":[110],"Using":[111],"method":[113],"last":[115],"visit":[116,195],"carried":[117],"forward,":[118],"visual":[120],"acuity":[121],"(VA)":[122],"6.42":[127],"ETDRS":[128,148],"letters":[129],"better":[130,222],"than":[131,228],"VA":[133],"at":[137,191],"final":[139],"assessment.":[140],"had":[145],"mean":[147],"gain":[150],"21.50":[152],"(":[153,196],"P":[154,197],"=":[155,198],".06)":[156],"initial":[159],"baseline":[160,174],"vision.":[161],"The":[162],"average":[163],"amount":[164],"decrease":[166],"OCT":[168,226],"central":[169],"subfield":[170],"thickness":[171],"lower":[176],"(80.9":[180],"\u00b1":[181,188],"129.8":[182],"\u00b5m)":[183,190],"vs":[184],"(102.8":[187],"90.40":[189],"follow-up":[194],".25).":[199],"Conclusions:":[200],"Approved":[201],"CNV":[204,216],"POHS":[207,219],"is":[208],"limited.":[209],"Adjuvant":[210],"corticosteroid":[211],"may":[220,232],"provide":[221],"long-term":[223],"vision":[224],"outcomes":[227],"alone":[230],"offer":[233],"additional":[235],"therapy":[236],"option":[237],"for":[238],"these":[239],"patients.":[240]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2023-10-13T00:00:00"}